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Background/aim: We aimed to examine the effect of plastic biliary stenting in the treatment of common bile duct (CBD) stones.
Materials and methods: The data of 13,034 patients in our unit who had endoscopic retrograde cholangiopancreatography (ERCP)
between 2008 and 2015 were scanned retrospectively.
Results: A biliary stent was placed in 61 of 74 patients. While the plastic biliary stent was placed in patients, the mean stone size after the
1st ERCP was 20 mm and the bile duct size was 13 mm. At the time of the 2nd ERCP conducted approximately 73.9 days later, the mean
stone size was found to be 15 mm and the bile duct size was 12 mm. With recurrent ERCPs, the CBD stone was successfully removed in
53 patients but could not be removed in 8 patients. Among the 53 successful cases, 29 removals were successful in the 2nd ERCP session,
16 were successful in the 3rd session, 2 were successful in the 4th session, 1 was successful in the 5th session, 4 were successful in the 6th
session, and 1 was successful in the 7th session.
Conclusion: For CBD stones that cannot be removed by standard methods, temporary plastic stenting is an alternative method.
Key words: Cholelithiasis, difficult common bile duct stone, endoscopic retrograde cholangiopancreatography, plastic stent

1. Introduction
Choledocholithiasis is the most common gastrointestinal
disorder in the practice of therapeutic endoscopy.
Endoscopic retrograde cholangiopancreatography (ERCP)
is the primary technique combined with the endoscopic
sphincterotomy, balloon, and basket technique that is used
to remove common bile duct (CBD) stones. Although the
success of stone extraction with ERCP is 80%–85% (1), in
10%–15% of cases, the stone cannot be removed due to
its size (>15 mm), the distal CBD being short (<36 mm)
and narrow-angled (<135°), or the impact of the stone and
anatomical challenges (2).
Cases of patients whose stones cannot be removed with the
basket and balloon catheter after endoscopic sphincterotomy
are referred to as difficult cases (3). In difficult cases of biliary
stenting, electrohydraulic lithotripsy (4,5), extracorporeal
shock wave lithotripsy (6,7), and laser lithotripsy (8) can be
used as alternatives to the standard method. However, for
elderly patients with high comorbidity and patients at highrisk in surgical procedures and other endoscopic procedures,
biliary stenting becomes prominent.
* Correspondence: dr.mahmutyuksel@hotmail.com

When the attempt to remove a CBD stone fails, a
temporary plastic stent can be placed in the patient in order
to facilitate the drainage of bile, function as a bridge for
advanced methods, and minimize the impact of the stone.
Previous studies have shown that this type of stent enables
the reduction of stones and facilitates their removal (9).
In this study, we aimed to examine the effect of biliary
stenting on the treatment of CBD stones.
2. Materials and methods
This study was conducted at the Yüksek İhtisas Training
and Research Hospital Gastroenterology Clinic in Turkey
between 1 January and 1 June 2015.
In this study, the data of 13,034 patients who
underwent ERCP between February 2008 and January
2015 were scanned retrospectively. Large-sized multiple
stones that could not be removed in the first operation
using the basket and balloon catheter after endoscopic
sphincterotomy were accepted as difficult stones. The data
of 74 patients (among the patients in whom a plastic stent
was placed due to a difficult stone) whose file information
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we could obtain, i.e. those with a recorded cholangiogram
from which we could take measurements and those
without nasobiliary drainage, were analyzed.
The files and recorded cholangiograms of patients
enrolled in the study were examined retrospectively and
their choledochal diameters (widest diameter) and stone
diameters (largest stone) in the first and subsequent
sessions were recorded, using their duodenoscope
diameters as a reference.
Both features (stone and choledochal diameters) of
patients in whom a plastic stent was placed in due to a
difficult stone, between the first operation and subsequent
operations, and the features of “successful” groups,
in which the stones were entirely and endoscopically
removed, as well as “unsuccessful” groups, in which the
stones could not be entirely cleared, were examined.
Patients were evaluated in terms of postprocedure
complications of acute pancreatitis and cholangitis. Acute
pancreatitis was defined as newly emerging abdominal
pain requiring hospitalization for more than a night and
an amylase/lipase level 3 times higher than normal after
ERCP, and cholangitis was defined as fever lasting for
more than 24 h due to biliary causes.
2.1. Endoscopic retrograde cholangiopancreatography
and stenting
ERCP was performed using the Olympus TJF-240 and
260 (Olympus Medical System Corp., Tokyo, Japan)
series duodenoscope after topical lidocaine and pharynx
anesthesia, followed by sedation with intravenous
pethidine HCl and midazolam. On reaching the second
part of the duodenum, bowel movements were controlled
by intravenous hyoscine-N-butyl bromide, or glucagon
when the former was ineffective. A contrast medium was
injected through the papilla cannulation with the help of
a guide wire. When the stone was detected, endoscopic
sphincterotomy was applied for naive patients and for
those who had not undergone sphincterotomy before,
large-diameter balloon (10–12 mm) dilatation was applied
either directly or in addition to the sphincterotomy. Stones
were removed using the balloon or the basket technique
as well as using mechanical lithotripsy when necessary. A
plastic stent was placed in patients whose stone could not
be removed following the first procedure with basket and
balloon catheter, due to various reasons beyond endoscopic
sphincterotomy. These patients were considered as having
difficult stones. Stent diameters were selected as 7F, 10F, or
11.5F depending on the characteristics or on the degree
of the cases. Among the cases with biliary stent, the
Amsterdam type stent was placed in 69 of them, a single
pigtail stent (Boston Scientific Corporation, Natick, MA,
USA) was placed in 1 of them, and a double pigtail stent
was placed in 4 of them.
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2.2. Statistical analysis
SPSS 20 for Windows (IBM Corp., Armonk, NY, USA)
was used for statistical assessments. The suitability of
variables to normal distribution was examined using
visual (histograms and probability plots) and analytical
(Kolmogorov–Smirnov/Shapiro–Wilk)
methods.
Descriptive analysis was presented using the median and
interquartile range for normally distributed variables (using
frequency tables for ordinal variables). Since choledochal
size and stone size showed an abnormal distribution, these
parameters were compared using the Wilcoxon test. P <
0.05 was considered statistically significant.
3. Results
CBD stones were determined in 5775 (44.3%) patients
out of the retrospectively scanned 13,034 patients. Among
these 5775 patients with CBD stones, the choledoch of
5368 patients (92.97%) was completely cleared of stones
in the first session. Among the remaining 407 (7.03%)
cases, various endoscopic procedures were applied for
333 (5.77%) of them, and a biliary stent was applied in
74 cases (1.28%), assuming that the stones were difficult
stones. Since 13 of the 74 patients with biliary stents did
not continue with the follow-up, the data of 61 patients
(21 males, 40 females, average age: 68.4 years) were then
examined.
At their first admission, 9 patients (14.8%) had
cholangitis, 2 patients (3.2%) had pancreatitis,
and 50 patients (82%) had abdominal pain.
The papilla was naive in the stent and was placed in 38
cases (62.3%), with endoscopic sphincterotomy in 23
cases. A 10F stent was placed for 48 (78.6%) patients, 7F
was placed for 11, and 11.5F was placed for 2. One plastic
stent was placed for 58 patients (95.1%), 2 plastic stents for
2 patients (3.3%), and 3 plastic stents for 1 patient. In 13 (12
successful, 1 unsuccessful, 21.3%) of the 61 stents placed,
the patients’ papilla was at the edge of the diverticulum.
During ERCP, among 61 patients in the study group,
23 patients (37.7%), underwent balloon dilatation, 8
patients (13.1%) underwent the expansion of endoscopic
sphincterotomy, and 5 patients (8.2%) underwent both
balloon dilatation and the expansion of endoscopic
sphincterotomy. The remaining 25 patients (40.9%) had no
additional processing to carry out. In 28 patients (45.9%),
lithotripsy was needed. During these operations, bleeding
or perforation was not observed in any of the patients.
Cholangitis developed in a total of 4 patients (6.6%),
including 3 cases in which the stone could not be removed,
and the stent was placed within 30 days after the first ERCP
session; in 1 patient, a stent was placed after a second ERCP
session of stenting. Post-ERCP pancreatitis was observed
in 2 patients (3.3%) after the first ERCP session.
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Stone size was measured as an average of 20 mm (8–
42 mm) after the first session of ERCP, and it decreased
to about 15 mm (0–35 mm) in the second session (P <
0.001). Choledochal diameter was measured as an average
of 13 mm (6–25 mm) in the first session of ERCP, and
it decreased to 12 mm (6–23 mm) in the second session
(Figure 1). The application period for the second ERCP in
patients was determined as an average of 73.9 days.
CBD stones were removed from 53 of the 61 patients
with biliary stents in repeated ERCP sessions (successful).
Surgery was conducted on the remaining 8 patients
(unsuccessful).
The features of the successful and unsuccessful cases
after biliary stents were placed in patients are presented in
the Table. Stone and choledoch sizes according to ERCP

sessions in the successful and the unsuccessful groups are
shown in Figure 2. There was no significant difference
between the two groups in terms of demographic and
clinical findings. Sphincterotomy was applied in 21 of the
patients who underwent a successful operation and in 2 of
the patients underwent a failed operation.
In patients who underwent a successful operation,
after stent placement in the 1st ERCP session, 29 (54.7%)
removals were successful in the 2nd session, 16 (30.1%)
were successful in the 3rd session, 2 (3.8%) were successful
in the 4th session, 1 (1.9%) was successful in the 5th
session, 4 (7.6%) were successful in the 6th session, and 1
(1.9%) was successful in the 7th session (Figure 3). In the
successful group, all of the stones were cleared within 2.7
± 1.4 months.

25
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Figure 1. The change in stone and choledochal size in patients with biliary stent after the
1st and 2nd sessions of ERCP.
Table. The features of successful and unsuccessful cases after biliary stent.
Variables

Successful treatment

Unsuccessful treatment

n = 53

n=8

P

Age (years)

67.6 ± 15.6

74.3 ± 10.3

0.140

Sex, female, n (%)

33 (62.3)

7 (87.5)

0.161

Stone size (1st session)

20 (8–40)

20.5 (10–42)

0.584

Stone size (2nd session)

15 (0–30)

16 (13–35)

0.206

Choledochal size (1st session)

13 (6–25)

14 (9–20)

0.974

Choledochal size (2nd session)

12 (6–23)

13 (11–20)

0.341

Presence of diverticula, n (%)

12 (22.6)

1 (12.5)

0.514

Gall-bladder operation, n (%)

21 (39.4)

2 (25)

0.426

Number of ERCP sessions, n (min–max)

2 (2–6)

2 (1–7)

0.369

Stent length, F (min–max)

11.6 (9–18)

11 (9–12)

0.124

2nd ERCP time, days (min–max)

70 (2–401)

121 (16–125)

0.093

ERCP: Endoscopic retrograde cholangiopancreatography.
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Figure 2. The comparison of stone and choledochal size in patients with successful and
unsuccessful process after the 1st and 2nd procedure.
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Figure 3. The success rate (%) of stone removal in the successful group based on ERCP
procedure.

4. Discussion
The sensitivity and the specificity of ERCP in the diagnosis
of CBD stones are over 95% (10). After endoscopic
sphincterotomy, CBD stones are treated successfully in
85%–90% of patients with basket and balloon catheter
(3,4).
Some factors may influence the success of the
ERCP. These factors are the size of the stone, multiple
stones, impaction of the stone, CBD in sigmoid shape,
a periampullary diverticulum that obstructs sufficient
sphincterotomy, stenosis, and patients that undergo
biliodigestive surgeries (for example, previous Billroth II
gastrectomy) (4,11–14).
When an attempt to remove a CBD stone fails, a
temporary plastic stent can be placed in the patient
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in order to facilitate the drainage of bile, function as a
bridge for advanced methods, and prevent the stone from
being impacted. Previous studies have shown that plastic
stenting enables the reduction of stones and facilitates their
removal (9). Therefore, the biliary stent and lithotripsy
being another method can be considered as a projected
method, prior to surgery, in impacted and intrahepatic
stones (15).
The reduction in stone size after plastic stenting can
be explained as follows: mechanical friction between the
biliary stent and stone causes fragmentation, and, over
time, the fragmented stone shrinks in size. Millimetricsized fragmented stones drain with the stent. The plastic
stent moves easily and is compactible with body and bowel
movements; it causes more friction than expected, and
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also allows for greater drainage (11). Thus, this method
provides a major contribution to the fragmentation of
CBD stones, as well as allowing for biliary drainage (11–
14).
Biliary stenting is a practical alternative for elderly
patients and other patients who are at high risk due to
their comorbid conditions for endoscopic and surgical
procedures (16).
In a study conducted by Chan et al., a plastic biliary
stent was placed in 46 patients whose stones could not
be removed by ERCP in the first session. In the second
session of ERCP, the CBD stone was successfully removed
from 38 (60.9%) patients (12). In another study, in the
2nd session of 20 patients who underwent a first failed
ERCP session for CBD stones and had 7F plastic stenting,
which was performed after 6 months, 11 cases (55%) were
successful (13). In a study conducted by Katsinelos et al.,
among 25 patients who had an unsuccessful first session
of ERCP, 11 of them had a successful second session after
biliary stenting (14). In another study, among 40 patients
who were observed after having a biliary stent inserted
for 65 days, 37 (93%) of them had their stones cleared
in the second session (11). In a study by Maxton et al., a
temporary biliary stent was placed with ERCP in 79 of 283
patients with CBD stones. After an average of 4.3 months,
the result was successful in 50 (63%) patients (17).
In our study, the stones were successfully removed from
53 patients out of 61 for whom a plastic stent was placed
with ERCP. When we considered the number of sessions
in the 53 successful patients, the success rate was 73.7%
in the 2nd or 3rd session. The stent stayed an average of
73.9 days. When we compare these results with the studies
in literature, we see that our success rate is above the
average reported in the literature and the duration of stone
removal is below the average in literature. This may be
due to endoscopists’ experience, features of the stent, and
differences between average stone size and number among
the study groups.
It was reported that the periampullary diverticulum
was observed in 5%–32% of the patients examined with
a duodenoscope (18). In our study, while the papilla was
on the edge of the diverticulum in 12 (22.6) patients in
the successful group, it was on the edge in 1 patient in the
unsuccessful group. Our results were consistent with the
literature and did not differ significantly between the two
groups.
It has been reported that impacted CBD stones and
stone sizes are important determinants of endoscopic
success (19,20). As was shown in a multicenter study, while
the success rate is 90%–100% in cases of small stones with
a diameter of less than 2 cm, it decreases to 68%–83% in
cases of larger stones with a diameter of 3 cm or more (21).
It was reported in the studies by Lauri et al. that stones

smaller than 10 mm were able to be extracted. However,
when the diameter of the stone exceeds 15 mm, the rate
of success is 12%, and this rate reduces when the stone
diameter is more than 18 mm (22). The average stone
size in patients with plastic stent was 20 mm in our study.
Regardless of this, the success of stone removal in ERCP
was rated quite high.
It is known that when the removal of CBD stones
fails using the standard method, a biliary stent minimizes
the impact of the stone and functions as a bridge before
surgery. Surgery was also recommended to 6 patients
in our study. Lifelong transient biliary stenting is an
alternative method for patients whose choledochal stone
cannot be removed with ERCP and who cannot undergo
surgery due to comorbid diseases or due to advanced age
(23). In our study, 2 patients were followed with transient
biliary stenting at intervals of 2–3 months, due to comorbid
diseases.
Bile duct stones are removed after sphincterotomy
with a 85%–90% success rate using a basket and balloon
catheter. However, some additional methods, such as
endoscopic sphincterotomy expansion, wide balloon
dilatation to the sphincter, and mechanic lithotripsy, are
required in patients whose stone cannot be removed.
In our study, some patients underwent an additional
balloon dilatation, some had endoscopic sphincterotomy
expansion, and some underwent both balloon dilatation
and endoscopic sphincterotomy.
Mechanical lithotripsy was first described in 1982 by
Riemann et al. and has been widely used in the treatment
of difficult stones (24). In our study, lithotripsy was needed
in 28 patients (25/53, 45.9%).
ERCP often results in certain complications, including
pancreatitis and cholangitis.
In a study of 83 patients by Ang et al., plastic biliary
stenting caused cholangitis, biliary pancreatitis, obstructive
jaundice, and biliary colic in 71%, 3.6%, 21.4%, and 3.6%
of patients, respectively, during an average period of 19
months of follow-up (25). Hui et al. reported cholangitis
in 63.2% of their patients (26).
In our study, cholangitis developed in 4 patients (6.6%)
and pancreatitis developed in 2 patients (3.3%) in the first
30 days among 61 patients. This rate was found to be very
low compared to the rate reported in the literature. This
may most likely be due to the short follow-up time or
expert endoscopist.
The main limitation of our study is its retrospective and
single-centered design. However, this limitation can be
ignored since our ERCP unit is the largest unit in Turkey
that accepts the highest number of patients.
In conclusion, in our study, stones were successfully
removed in 86.9% of the patients in whom a biliary stent
was placed. Our study, unlike other studies, reveals the
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effect of biliary stents on stone treatment, as well as the
shrinkage effect on the diameter of the choledoch. Although
difficult stones constitute a problem for the endoscopist,
they can successfully and endoscopically be removed to a
large extent. In cases of biliary tract stones that cannot be
removed by standard methods, placing a temporary plastic
stent is an alternative method. We have shown in our study

that stones can be completely and safely removed in a few
sessions in difficult cases after a short-term plastic stent
placement. In addition, endoscopic biliary stenting is a
practical alternative method used for elderly patients and
other high-risk patients due to their comorbid conditions
for surgical procedures, also functioning as a bridge for
surgery.
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